Our recent studies in EGFR mutant lung cancer cell lines and murine head and neck cancer cells demonstrated a TKI-stimulated IFNγ transcriptional response accompanied by increased chemokine expression7,29. The gene discussed is EGFR; the disease is lung carcinoma.